Skip to main content
Log in

DNase1 activity in systemic lupus erythematosus patients with and without nephropathy

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of the study is to determine whether the activity of DNase1 is associated to the presence of nephropathy in patients with SLE. Forty-five patients affected with SLE and renal involvement were analyzed. The type of renal involvement was type III or IV glomerulonephritis. At least two serum samples were withdrawn from each patient, one obtained in a renal flare and the other obtained in a period of clinical stability. C3 and C4 complement levels and anti-DNA antibodies were determined. DNase1 activity was measured using a radial enzyme-diffusion method. Results suggest that when comparison of DNase1 activity was established between samples obtained during a phase of active renal involvement and those obtained in the clinically stable phase, we did not find statistically significant differences. When the comparison was performed with matched samples of the same patient, DNase1 activity was lower when patients had active renal involvement than when samples were taken in clinically stable phase (21.21 μg/ml ± 16.47 vs. 25.62 μg/ml ± 18.81, p < 0.05). No difference in DNase1 activity was observed between samples positive or negative for anti-DNA antibodies. No difference in DNase1 activity was found in patients with normal or decreased levels of C3 (25.09 μg/ml ± 17.78 vs. 20.01 μg/ml ± 16.15, p = 0.073) or C4 (23.52 μm/ml ± 16.60 vs. 19.62 μg/ml ± 17.54, p = 0.060). We conclude that low DNase1 activity is associated to the active phase of type III or IV nephropathy. Therefore, it is possible that this enzyme plays an important role in the development of SLE nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SLE:

Systemic lupus erythematosus.

dsDNA:

Double-stranded DNA

ACR:

American College Rheumatology

References

  1. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501–537

    Article  CAS  PubMed  Google Scholar 

  2. Bruneau C, Benveniste J (1979) Circulating DNA:anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation. J Clin Invest 64:191–198

    Article  CAS  PubMed  Google Scholar 

  3. Brinkman K, Termaat R, Berden JH, Smeenk RJ (1990) Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today 11:232–234

    Article  CAS  PubMed  Google Scholar 

  4. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Goral A, de Ramon E, Fernandez-Nebro A, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ruiz-Irastorza G, Ingelmo M, Hughes GR (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167–175

    Article  CAS  Google Scholar 

  5. Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children—a review of 167 patients. Pediatrics 94:335–340

    CAS  PubMed  Google Scholar 

  6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113–124

    CAS  Google Scholar 

  7. Mak A, Mok CC, Chu WP, To CH, Wong SN, Au TC (2007) Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus 16:28–34

    Article  CAS  PubMed  Google Scholar 

  8. Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, Limburg P, Gmelig-Meyling F, Kater L, Kallenberg C (1995) Prevention of relapses in systemic lupus erythematosus. Lancet 345:1595–1599

    Article  CAS  PubMed  Google Scholar 

  9. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG (1990) Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 33:634–643

    Article  CAS  PubMed  Google Scholar 

  10. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–324

    Article  CAS  PubMed  Google Scholar 

  11. Graham KL, Utz PJ (2005) Sources of autoantigens in systemic lupus erythematosus. Curr Opin Rheumatol 17:513–517

    Article  CAS  PubMed  Google Scholar 

  12. Walport MJ (2000) Lupus, DNase and defective disposal of cellular debris. Nat Genet 25:135–136

    Article  CAS  PubMed  Google Scholar 

  13. Koutouzov S, Jeronimo AL, Campos H, Amoura Z (2004) Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 30:529–558

    Article  PubMed  Google Scholar 

  14. Laskowski M (1971) Deoxyribonuclease I. In: Boyer PD (ed) The enzymes, 3rd edn, vol 4. New York Academic Press, NY, pp 289–311

  15. Lacks SA (1981) Deoxyribonuclease I in mammalian tissues. Specificity of inhibition by actin. J Biol Chem 256:2644–2648

    CAS  PubMed  Google Scholar 

  16. Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R, Polzar B (1995) A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 198:161–174

    CAS  PubMed  Google Scholar 

  17. Napirei M, Wulf S, Mannherz HG (2004) Chromatin breakdown during necrosis by serum DNase1 and the plasminogen system. Arthritis Rheum 50:1873–1883

    Article  CAS  PubMed  Google Scholar 

  18. Martinez-Valle F, Balada E, Ordi-Ros J, Bujan-Rivas S, Sellas-Fernandez A, Vilardell-Tarres M (2009) DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features. Lupus 18:418–423

    Article  CAS  PubMed  Google Scholar 

  19. Chitrabamrung S, Bannett JS, Rubin RL, Tan EM (1981) A radial diffusion assay for plasma and serum deoxyribonuclease I. Rheumatol Int 1:49–53

    Article  CAS  PubMed  Google Scholar 

  20. Chitrabamrung S, Rubin RL, Tan EM (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60

    Article  CAS  PubMed  Google Scholar 

  21. Macanovic M, Lachmann PJ (1997) Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin Exp Immunol 108:220–226

    Article  CAS  PubMed  Google Scholar 

  22. Tan EM, Schur PH, Carr RI, Kunkel HG (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45:1732–1740

    Article  CAS  PubMed  Google Scholar 

  23. Schur PH, Sandson J (1968) Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278:533–538

    Article  CAS  PubMed  Google Scholar 

  24. Miniter MF, Stollar BD, Agnello V (1979) Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 22:959–968

    Article  CAS  PubMed  Google Scholar 

  25. Berden JH (1997) Lupus nephritis. Kidney Int 52:538–558

    Article  CAS  PubMed  Google Scholar 

  26. Bell DA, Morrison B, VandenBygaart P (1990) Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 85:1487–1496

    Article  CAS  PubMed  Google Scholar 

  27. Dieker JW, van der Vlag J, Berden JH (2002) Triggers for anti-chromatin autoantibody production in SLE. Lupus 11:856–864

    Article  CAS  PubMed  Google Scholar 

  28. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH (2004) Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 22:139–145

    Article  CAS  PubMed  Google Scholar 

  29. Gaipl US, Sheriff A, Franz S, Munoz LE, Voll RE, Kalden JR, Herrmann M (2006) Inefficient clearance of dying cells and autoreactivity. Curr Top Microbiol Immunol 305:161–176

    Article  CAS  PubMed  Google Scholar 

  30. Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, Lee KD, Gavalchin J, Kaplan MJ (2006) Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol 176:2095–2104

    CAS  PubMed  Google Scholar 

  31. White S, Rosen A (2003) Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 15:557–562

    Article  CAS  PubMed  Google Scholar 

  32. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965–975

    Article  CAS  PubMed  Google Scholar 

  33. Peitsch MC, Irmler M, French LE, Tschopp J (1995) Genomic organisation and expression of mouse deoxyribonuclease I. Biochem Biophys Res Commun 207:62–68

    Article  CAS  PubMed  Google Scholar 

  34. Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, Kalden JR, Herrmann M (2004) Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 50:640–649

    Article  CAS  PubMed  Google Scholar 

  35. Suzuki N, Harada T, Mizushima Y, Sakane T (1993) Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 151:1128–1136

    CAS  PubMed  Google Scholar 

  36. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA (1998) Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 161:4467–4471

    CAS  PubMed  Google Scholar 

  37. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86–89

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernando Martinez-Valle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martinez-Valle, F., Balada, E., Ordi-Ros, J. et al. DNase1 activity in systemic lupus erythematosus patients with and without nephropathy. Rheumatol Int 30, 1601–1604 (2010). https://doi.org/10.1007/s00296-009-1199-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1199-6

Keywords

Navigation